Act Capital Management, LLC Myovant Sciences Ltd. Transaction History
Act Capital Management, LLC
- $72.5 Million
- Q3 2022
A detailed history of Act Capital Management, LLC transactions in Myovant Sciences Ltd. stock. As of the latest transaction made, Act Capital Management, LLC holds 60,000 shares of MYOV stock, worth $0. This represents 1.49% of its overall portfolio holdings.
Number of Shares
60,000
Previous 65,000
7.69%
Holding current value
$0
Previous $808,000
33.42%
% of portfolio
1.49%
Previous 1.13%
Shares
4 transactions
Others Institutions Holding MYOV
# of Institutions
6Shares Held
61.3KCall Options Held
0Put Options Held
0-
Four Thought Financial, LLC Venice, FL1KShares$00.0% of portfolio
-
American Portfolios Advisors Holbrook, NY219Shares$00.0% of portfolio
-
Wipfli Financial Advisors Llc,97Shares$00.0% of portfolio
-
Huntington National Bank Columbus, OH1Shares$00.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio
About Myovant Sciences Ltd.
- Ticker MYOV
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 96,802,800
- Description
- Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...